Press Releases

9/27/2017
Imaging3 Announces Filing of Proxy Statement
7/31/2017
Imaging3 Announces Successful Conclusion of Mandatory Self-Remediation Period
6/20/2017
Imaging3 Engages Intertek to Assist with Hazard Analytic Requirements Relating to the 510(k) Application with the FDA
6/12/2017
Imaging3 Engages Med-Device Consulting, Inc. to Assist on 510(k) Application with the FDA
6/5/2017
Imaging3 Announces $500,000 Debt Financing
5/9/2017
Imaging3 Explains the 10-K Amendment Just Filed
3/1/2017
CriTech Research Concludes Software Remediation on SmartScan Software
2/15/2017
Imaging3 Announces MoneyTV’s Interview of Scott Pancoast to Discuss the Company and its Prospects
2/10/2017
Imaging3 Clarifies Announcement Concerning Closing of the Company’s Bankruptcy Proceeding
2/6/2017
Imaging3 Announces Closing of the Company’s Bankruptcy Proceeding
1/20/2017
Imaging3 Announces Filing of Form 8-K
1/17/2017
Imaging3 and Key Shareholders Amend Notes and Warrants and Agree to Additional Debt Facility
1/12/2017
Imaging3 Announces Filing of 8K
1/12/2017
Imaging3 Announces MoneyTV’s Interview of Scott Pancoast to Discuss the Company and its Prospects
12/20/2016
Imaging3 Announces Filing of Annual Report on Form 10-K for the Year Ended December 31, 2012
12/20/2016
Imaging3 Announces Filing of Annual Report on Form 10-K for the Year Ended December 31, 2012
11/29/2016
Scott R. Pancoast Joins the Imaging3 Team
10/24/2016
Imaging3, Inc. (OTCQB: “IGNG”) Announces Denial of Vuksich Application for Writ of Certiorari by the United States Supreme Court
10/11/2016
Imaging3, Inc. (OTCQB: “IGNG”) Announces Execution of Consulting Service Agreement with Biologics Consulting Group, Inc.
9/14/2016
Imaging3, Inc. (OTCQB: “IGNG”) Announces execution of agreement with CriTech Research to Complete Software Verification, Validation and Remediation for the Company’s Planned FDA 510(k) Application